Inactive Instrument
InVitae Corp Share Price NYSE
Stocks
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| 08/08/24 | Invitae Corporation Announces Cessation of Kenneth D. Knight as Chief Executive Officer | CI |
| 08/08/24 | Invitae Corporation Announces Cessation of Ana J. Schrank as Chief Financial Officer | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Spirito
CEO | Chief Executive Officer | - | - |
Hoki Luk
IRC | Investor Relations Contact | - | - |
Robert Guigley
PRN | Corporate Officer/Principal | - | 04/09/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -.--% | +115.11% | +11.80% | 20.03B | |
| -2.19% | -4.26% | +139.97% | +105.56% | 4.52B | |
| -0.18% | -2.84% | +108.91% | +185.51% | 3.56B | |
| -2.73% | -0.20% | +51.67% | -32.29% | 2.23B | |
| -0.90% | +1.56% | -30.96% | -37.12% | 2.07B | |
| -1.25% | -6.52% | +189.25% | +256.77% | 1.92B | |
| -4.11% | -6.63% | +149.45% | -45.83% | 997M | |
| -0.54% | -4.03% | -7.28% | +32.69% | 855M | |
| -3.59% | -6.57% | -43.37% | -17.58% | 479M | |
| Average | -1.62% | -2.51% | +74.75% | +51.05% | 4.07B | |
| Weighted average by Cap. | -0.22% | -1.33% | +105.36% | +46.16% |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
